This on-demand video provides a comprehensive guide to tailoring treatment plans for upper tract urothelial carcinoma (UTUC) using the latest treatment strategies. It explores leveraging new clinical evidence and real-world data to make informed treatment decisions, particularly focusing on patient selection and monitoring and mitigating adverse events from chemoablative therapies. The expert-led video also introduces a downloadable UTUC FAQ resource for continued learning and reference.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/clinical-implications-latest-real-world-evidence-novel-low-grade-utuc-therapies
- Start Date: 2024-08-30 05:00:00
- End Date: 2024-08-30 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Urogen Pharma, Inc. - Amount: 31583.33 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest